↓ Skip to main content

Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

Overview of attention for article published in Trials, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
Published in
Trials, June 2019
DOI 10.1186/s13063-019-3362-z
Pubmed ID
Authors

Johannes S. Kern, Agnes Schwieger-Briel, Sandra Löwe, Mark Sumeray, Charles Davis, Anna E. Martinez

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 14%
Student > Master 8 13%
Other 6 9%
Researcher 6 9%
Student > Doctoral Student 5 8%
Other 11 17%
Unknown 19 30%
Readers by discipline Count As %
Medicine and Dentistry 15 23%
Nursing and Health Professions 11 17%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Chemical Engineering 3 5%
Agricultural and Biological Sciences 2 3%
Other 7 11%
Unknown 22 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2021.
All research outputs
#2,829,512
of 22,111,096 outputs
Outputs from Trials
#1,041
of 5,690 outputs
Outputs of similar age
#64,031
of 307,387 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 22,111,096 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,690 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,387 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them